Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation

Abroad (travel likely)RecruitingPHASE1

Conditions

Metabolic Dysfunction-Associated Steatotic Liver Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Taiwan University Hospital, Taipei, Taiwan
Contact: Study coordinator (Wei-Kai Wu) · weikaiwu0115@gmail.com · 886-0958-880-236
Contact: Principal Investigator (Ming-Shiang Wu)
Chun-Jen Liu (Sub-investigator)
Wei-Kai Wu (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effect of Ketone Esters on Liver Fat Content and Metabolic Function

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · Obesity · Overweight (BMI > 25)

Abroad (travel likely)RecruitingPHASE2

St Louis, United States

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Metabolic Dysfunction-Associated Steatotic Liver Disease · Metabolic Dysfunction-Associated Steatohepatitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chandler, United States · Tucson, United States

Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) · Liver Fibrosis/NASH · Non-Alcoholic Steato-Hepatitis (NASH)

Abroad (travel likely)Recruiting

Sherbrooke, Canada

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease · HIV (Human Immunodeficiency Virus)

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · La Jolla, United States